Organisation/Company: Università degli Studi di Messina
Research Field: Medical sciences
Researcher Profile: First Stage Researcher (R1) Recognised
Researcher (R2) Established Researcher (R3) Leading Researcher (R4)
Application Deadline: 03/10/2022
Type Of Contract: To be defined
This study aims to detect and verify genetic changes associated with increased
fracture risk in patients with acromegaly, hypercortisolism or growth hormone
deficiency. In detail, we will study the effects of snipes or mutations of
genes involved in Wnt and RANK/RANK-L/OPG pathways on the pathogenesis and
clinical manifestation of bone alteration and on the therapeutic response. In
every patients, fracture risk will be evaluated by bone densitometry,
trabecular bone score (TBS) calculation and clinical algorithms, usually
used in patients with primary osteoporosis.
allow remote monitoring of patients through the acquisition of vital
in a digital medical record and integrated with the data of the biomarkers
The evaluation of circulating biomarkers, in the
different stages of the disease,...
various types of human cancers.
advancements on the mechanisms underlying mTOR-driven tumorigenesis, which
Eligible destination country/ies for fellows:
Eligibility of fellows: country/ies of residence:
https: // progetti.unicatt.it/progetti-ateneo-roma-assegni-di-ricerca-
Organisation Type: Private with public mission